Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- CNRS
- Nature Careers
- Institut Pasteur
- CIML2000
- Universite de Montpellier
- Université de Caen Normandie
- AIix-Marseille University/A*MIDEX
- Aix-Marseille Université
- CNRS-Streinth
- Centre de recherche des Cordeliers
- Fondation Hôpital Rothschild
- Gustave Roussy / Inserm
- INSERM
- Inria, the French national research institute for the digital sciences
- Institut Curie - Research Center
- Paris Cardiovascular Research Center, Inserm U970
- Tour du Valat
- University of Rouen Normandy
- Université Savoie Mont Blanc
- Université de Limoges
- Université de Strasbourg
- 11 more »
- « less
-
Field
-
advances in mass spectrometry now make it possible to detect proteins at true cytokine-level concentrations with high sensitivity and molecular specificity. Targeted proteomics, in particular, enables
-
FieldAstronomyYears of Research ExperienceNone Additional Information Eligibility criteria - PhD in astrophysics or a related field. - Experience in data analysis. - Proficiency in Bayesian statistics and nonparametric
-
in R or Python Desired - evidence of strong computational skills and large dataset analysis - experience with hierarchical Bayesian modeling - expert knowledge of plant functional ecology - fluency in
-
and implement Bayesian graph neural networks and convolutional neural networks as surrogates for high-fidelity biomechanical models Quantify and propagate uncertainty, and develop strategies for model
-
-24-CE02-6823 ). • Identification of a target gene specific to Choristoneura fumiferana in mitochondrial DNA • Development of a qPCR and ddPCR protocol to quantify this target gene in sediment matrices
-
10 Apr 2026 Job Information Organisation/Company Gustave Roussy / Inserm Department U981 / Molecular Predictors and New Targets in Oncology Research Field Medical sciences » Cancer research
-
release. MIL-100 generates reactive oxygen species under Fenton-like and NIR activation and delivers sorafenib. SBA-15, functionalized with folic acid, targets cancer cells and releases doxorubicin
-
, supporting sustained nucleotide biosynthesis and ATP production; Targeting oxidative phosphorylation requires prior bioenergetic stratification of tumors using defined biomarkers. Leveraging a unique biobank
-
for personalized treatment or as novel actionable therapeutic targets. We focus on gastric cancer, for which we have cell lines, patient-derived xenografts, a syngeneic tumor model, and comprehensive patient tissue
-
biophysical and biological studies of a generation of PDAC-targeted photosensitisers like phenalenone. The design of the photosensitisers will ensure reactive oxygen species (ROS) generation under near visible